Phillip Bennett is a clinical academic with an interest in the application of basic and translational science in the prevention of preterm birth and other pregnancy complications. He trained at St George’s Hospital London (graduation 1982), began research as an MD student studying biochemistry at Royal Postgraduate Medical School in the 1980s (graduation 1988) and as a PhD student in molecular biology at RPMS in the early 1990s (graduation 1992). He became Fellow of the Royal College of Obstetricians and Gynaecologists in 2000, Fellow of the Maltese College of Obstetricians and Gynaecologists in 2005 and Fellow of the Academy of Medical Sciences in 2017.
Phillip Bennett was appointed Professor of Obstetrics and Gynaecology in 1994 and became Director of the Institute for Reproductive and Developmental Biology, Imperial College, in 2011. In 2014 he also became Imperial NHS Research Director for Women’s and Children’s Health, a clinical division which includes Laboratory Sciences and Medical Imaging.
Phillip Bennett has a longstanding in human parturition and preterm birth working to improve health of pregnant women and preterm neonates through basic science and translational research and applying those finding to clinical practice. He has worked extensively over 25 years with industry undertaking basic science and preclinical studies to identify new targets in preterm labour, and developing novel drugs from discovery through to phase three trials and clinical application. In the past five years Bennett’s work has focused upon using large data sets from –omics and other studies in understanding the relationships between the innate and adaptive immune system, bacterially derived danger signals, and the pregnancy microbiome upon the risk of prematurity, their interactions with therapeutic strategies and the identification of a range of biomarkers for clinical prediction and prevention.